Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Person › Details

Manuel Litchman (Mustang Bio Inc. (Nasdaq: MBIO))

Litchman, Manuel (Mustang Bio 201704– CEO before Arvinas + Novartis Pharmaceuticals Corp)

 

Organisations Organisation Mustang Bio Inc. (Nasdaq: MBIO)
  Former/major organisation Arvinas Inc. (Nasdaq: ARVN)
  Group Arvinas (Group)
Products Product gene therapy
  Product 2 PROTAC technology (proteolysis targeting chimeric molecules)
     

   
Record changed: 2020-11-07

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px


More documents for Manuel Litchman


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Cardiovascular Health in Berlin-Brandenburg 650x300px




» top